Prelude Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,282
| Closed | -$1.32M | – | 1003 |
|
|
2023
Q2 | $1.32M | Buy |
15,282
+554
| +4% | +$48K | 0.09% | 231 |
|
|
2023
Q1 | $1.43M | Buy |
14,728
+64
| +0.4% | +$6.22K | 0.09% | 245 |
|
|
2022
Q4 | $1.52M | Buy |
14,664
+11,052
| +306% | +$1.14M | 0.08% | 245 |
|
|
2022
Q3 | $306K | Sell |
3,612
-6,170
| -63% | -$523K | 0.01% | 837 |
|
|
2022
Q2 | $811K | Buy |
+9,782
| New | +$811K | 0.02% | 496 |
|
|
2021
Q1 | – | Sell |
-7,105
| Closed | -$623K | – | 1113 |
|
|
2020
Q4 | $623K | Buy |
+7,105
| New | +$623K | 0.02% | 311 |
|
|
2020
Q3 | – | Sell |
-4,177
| Closed | -$515K | – | 1401 |
|
|
2020
Q2 | $515K | Buy |
4,177
+1,209
| +41% | +$149K | 0.03% | 278 |
|
|
2020
Q1 | $251K | Sell |
2,968
-6,772
| -70% | -$573K | 0.02% | 229 |
|
|
2019
Q4 | $824K | Buy |
9,740
+9,657
| +11,635% | +$817K | 0.03% | 231 |
|
|
2019
Q3 | $6K | Sell |
83
-11,550
| -99% | -$835K | ﹤0.01% | 1052 |
|
|
2019
Q2 | $996K | Buy |
11,633
+6,787
| +140% | +$581K | 0.05% | 178 |
|
|
2019
Q1 | $430K | Buy |
4,846
+1,200
| +33% | +$106K | 0.02% | 309 |
|
|
2018
Q4 | $310K | Sell |
3,646
-3,491
| -49% | -$297K | 0.02% | 399 |
|
|
2018
Q3 | $692K | Buy |
7,137
+2,758
| +63% | +$267K | 0.04% | 286 |
|
|
2018
Q2 | $413K | Buy |
4,379
+95
| +2% | +$8.96K | 0.03% | 458 |
|
|
2018
Q1 | $347K | Sell |
4,284
-5,952
| -58% | -$482K | 0.03% | 470 |
|
|
2017
Q4 | $913K | Buy |
10,236
+7,742
| +310% | +$691K | 0.07% | 234 |
|
|
2017
Q3 | $232K | Sell |
2,494
-2,781
| -53% | -$259K | 0.02% | 538 |
|
|
2017
Q2 | $479K | Buy |
+5,275
| New | +$479K | 0.05% | 296 |
|
|
2017
Q1 | – | Sell |
-2,903
| Closed | -$240K | – | 1438 |
|
|
2016
Q4 | $240K | Buy |
2,903
+872
| +43% | +$72.1K | 0.03% | 477 |
|
|
2016
Q3 | $188K | Sell |
2,031
-2,938
| -59% | -$272K | 0.02% | 535 |
|
|
2016
Q2 | $387K | Sell |
4,969
-1,396
| -22% | -$109K | 0.05% | 302 |
|
|
2016
Q1 | $525K | Sell |
6,365
-3,756
| -37% | -$310K | 0.07% | 262 |
|
|
2015
Q4 | $1.06M | Buy |
10,121
+1,494
| +17% | +$156K | 0.16% | 128 |
|
|
2015
Q3 | $909K | Sell |
8,627
-963
| -10% | -$101K | 0.13% | 167 |
|
|
2015
Q2 | $1.31M | Sell |
9,590
-725
| -7% | -$99.2K | 0.18% | 139 |
|
|
2015
Q1 | $1.29M | Buy |
10,315
+6,471
| +168% | +$806K | 0.18% | 142 |
|
|
2014
Q4 | $347K | Sell |
3,844
-1,330
| -26% | -$120K | 0.05% | 403 |
|
|
2014
Q3 | $373K | Buy |
5,174
+1,147
| +28% | +$82.7K | 0.05% | 437 |
|
|
2014
Q2 | $251K | Sell |
4,027
-4,091
| -50% | -$255K | 0.03% | 568 |
|
|
2014
Q1 | $554K | Buy |
8,118
+3,062
| +61% | +$209K | 0.07% | 311 |
|
|
2013
Q4 | $356K | Hold |
5,056
| – | – | 0.06% | 415 |
|
|
2013
Q3 | $365K | Sell |
5,056
-7,665
| -60% | -$553K | 0.06% | 320 |
|
|
2013
Q2 | $709K | Buy |
+12,721
| New | +$709K | 0.15% | 143 |
|